[Press release] AbbVie announces positive CHMP opinion for MAVIRET® (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C infection – European AIDS Treatment Group
Posted by admin
on Monday, May 25, 2026 at 12:31 am — No Comments | Leave a Comment
Leave a Comment